Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,772 across all filing types
Latest filing 2026-04-08 Earnings Release
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Evotec Announces Fourth Quarter and Full-Year 2025 Results: Foundation for Profitable Growth
Earnings Release Classification · 1% confidence The document is a press release announcing the fourth quarter and full-year 2025 financial results, with key highlights, business updates, and guidance. It follows the standard format of an earnings announcement rather than a full annual/quarterly report or investor presentation. Therefore, it fits the definition of an Earnings Release (ER). FY 2025
2026-04-08 English
Annual financial report 2025
Annual Report
2026-04-08 English
Evotec Nominates Dieter Weinand as Supervisory Board Chairman
Board/Management Information Classification · 1% confidence The document is a corporate news announcement nominating a new Supervisory Board Chairman, detailing a change in the company’s board leadership. This falls squarely under announcements of changes in the board of directors or senior management, matching the Board/Management Information category.
2026-04-07 English
Major Shareholding Notification 2026
Major Shareholding Notification Classification · 1% confidence The document is a formal notification under German Securities Trading Act (WpHG) Article 40 of acquired/disposed voting rights and instruments, detailing thresholds crossed and total positions. This clearly fits the definition of a Major Shareholding Notification, as it reports changes in significant share ownership levels.
2026-04-02 English
Evotec Appoints Dr. Ashiq H. Khan as Chief Commercial Officer
Board/Management Information Classification · 1% confidence The document is a corporate news press release announcing the appointment of a new Chief Commercial Officer, which is a senior management change. This fits the “Board/Management Information” category.
2026-04-01 English
Report Publication Announcement 2026
Report Publication Announcement Classification · 1% confidence The document is a preliminary announcement notifying stakeholders of the upcoming publication dates and URLs for the company’s quarterly/interim financial statements. It does not contain the actual report content but merely states when and where the reports will be disclosed, fitting the definition of a Report Publication Announcement.
2026-03-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.